{"favorite_id": 4023, "calc_type": "calculator", "dosing": true, "full_title_en": "Naloxone Drip Dosing", "short_title_en": "Naloxone Drip Dosing", "medium_description_en": "Doses naloxone for acute opioid overdose.", "short_description_en": "Opioid reversal.", "before_use": "This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.", "instructions_en": "<p>Use in patients with respiratory or central nervous system depression from opioid analgesic overdose.</p>", "purpose_en": ["Treatment"], "disease_en": ["Ingestion/Overdose"], "specialty_en": ["Emergency Medicine", "Toxicology", "Pharmacy"], "chief_complaint_en": ["Intoxication/Overdose"], "system_en": ["Any/All"], "search_abbreviation_en": ["Naloxone", "Narcan", "Naloxone drip", "Naloxone GTT"], "slug": "naloxone-drip-dosing", "seo": {"meta_description_en": "Naloxone Drip Dosing doses naloxone for acute opioid overdose.", "keywords_en": "Naloxone, narcan, naloxone drip, naloxone gtt, opiate overdose, OD, opioid overdose"}, "content": {"how_to_use": {"use_case_en": "<ul> <li>Respiratory or CNS depression from opioid analgesic overdose.</li> <li>Respiratory depression responsive to naloxone administration.</li> <li>Respiratory depression requiring more than one IV dose of naloxone.</li> </ul>", "pearls_pitfalls_en": "<ul> <li>Goal is to maintain the same level of reversal following initial naloxone bolus.</li> <li>Bolus dose necessary to reverse the respiratory depressant effects of the opioid overdose should be determined clinically.</li> <li>Bolus dose = total dose required in the first hour.</li> </ul>", "why_use_en": "<p>The half-life of naloxone is between 30 and 100 minutes. Because the duration of action of most available opioids exceeds that of naloxone, repeated administration or a continuous IV infusion may be required to prevent recurrence of respiratory depression.</p>"}, "next_steps": {"advice_en": "<ul> <li>Consider gastric decontamination for orally ingested opioid. Look for and remove patches if applicable.</li> <li>The drip may require frequent adjustment based on clinical status.</li> </ul>", "management_en": "<p>Consider admission to an intensive care setting to prevent recurrent CNS and/or respiratory sequelae or withdrawal.</p>", "critical_actions_en": "<ul> <li>Adjust drip based on clinical status.</li> <li>Monitor patient in a intensive care setting.</li> </ul>"}, "about": {"formula_en": "<p>Continuous IV infusion starting rate (mg/hr) = (\u2154\u00d7 bolus dose mg) per hour. Half of the bolus dose may be administered 15 minutes after starting drip.</p> <p>Bolus dose = total dose required in the first 1 hour.</p> <p>Titrate to respiratory rate, hypoxia and/or CNS depression.</p> <p>Decrease rate if withdrawal symptoms occur.</p>", "more_info_en": "", "evidence_based_medicine_en": "<p>Naloxone dosing was studied by <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/3963538\" target=\"_blank\">Goldfrank et al 1986</a><strong>&nbsp;</strong>in a two-phase pharmacokinetic study.</p>\n<p>Phase I: Determining rate of elimination of naloxone.</p>\n<ul>\n<li>7 volunteers.</li>\n<li>IV bolus dose of naloxone given.</li>\n<li>Serial plasma naloxone levels measured.&nbsp;</li>\n</ul>\n<p>Phase II: Determining volume of distribution and mean beta rate of elimination.</p>\n<ul>\n<li>10 volunteers.</li>\n<li>2 mg or 4 mg IV bolus naloxone given, followed by continuous infusion of either 1.5 mg/hr or 3 mg/hr.</li>\n<li>Serial plasma naloxone levels measured.</li>\n</ul>\n<p>Based on these parameters, a computer simulation determined:</p>\n<ul>\n<li>\u2154 of the initial bolus dose will maintain plasma naloxone levels equal to or greater than naloxone levels that would have existed 30 minutes after the bolus dose.</li>\n<li>A second bolus dose equal to half the initial bolus should be administered at 15 minutes to achieve predicted steady-state concentrations effectively.</li>\n</ul>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/3963538", "text": "Goldfrank L, Weisman RS, Errick JK, Lo MW. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med. 1986;15(5):566-70."}], "Other References": [{"href": "http://www.nejm.org/doi/full/10.1056/NEJMra1202561", "text": "Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146-55."}, {"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726910/pdf/v022p00612.pdf", "text": "Clarke S, Dargan P, Jones A. Naloxone in opioid poisoning: walking the tightrope. Emergency Medicine Journal\u202f: EMJ. 2005;22(9):612-616. doi:10.1136/emj.2003.009613."}], "Validation": [{"href": "", "text": ""}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": [{"description": "<p>Elie Harmouche, MD, is a medical toxicology fellow at the department of emergency medicine at New York University. He was born and raised in Beirut, Lebanon, and he received his medical degree from the American University of Beirut. He completed a residency in emergency medicine at Henry Ford Hospital in Detroit, MI and served as chief resident in his final year, followed by fellowship in toxicology at NYU Langone/Bellevue Hospital Center in New York City. His areas of interest include toxicology, addiction and substance use, simulation medicine, resuscitation, and critical care.</p>", "firstName": "Elie", "img": "https://cdn-web-img.mdcalc.com/people/elie-harmouche.jpg", "lastName": "Harmouche", "name": "Elie Harmouche, MD", "target": "elie-harmouche", "signedCOI": false, "hasDisclosure": []}]}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Lewis Goldfrank", "creator_info": {"about_en": "<p>Lewis Goldfrank, MD, FACEP, FAAEM, FAACT, FACMT, FACP, is the Herbert W. Adams Professor of Emergency Medicine at New York University. He is also the medical director of the New York City Poison Control Center. Dr. Goldfrank is perhaps best known as author and editor of the primary toxicology reference <em>Goldfrank's Toxicologic Emergencies</em>.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-lewis-goldfrank.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Goldfrank+LR%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "textbox", "label_en": "Bolus dose", "name": "bolus", "unit": "drugmg_naloxone", "conditionality": "", "optional": false, "tips_en": "Total dose required in the first hour", "unit_info": {"name": "Dosage", "conversion": 1, "error_min": -1, "error_max": 20, "warn_min": 0, "warn_max": 10, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "mg", "units_us": "mg"}}], "md5": "a0c9d93af6b391d2a4a78b7c12b13722", "cmeVersion": "4023.1", "related_calcs": [{"calcId": 4036, "short_title_en": "DigiFab (Digibind) Dosing", "slug": "digifab-digibind-dosing-digoxin-poisoning"}, {"calcId": 4026, "short_title_en": "High-dose Insulin Euglycemia Therapy (HIET)", "slug": "high-dose-insulin-euglycemia-therapy-hiet"}, {"calcId": 10290, "short_title_en": "IV Drip Rate Calculator", "slug": "iv-drip-rate-calculator"}]}